tiprankstipranks
P3 Health Partners (PIII)
NASDAQ:PIII
US Market

P3 Health Partners (PIII) Earnings Dates, Call Summary & Reports

Compare
110 Followers

Earnings Data

Report Date
May 07, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
-0.16
Last Year’s EPS
-0.16
Same Quarter Last Year
Moderate Buy
Based on 5 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Mar 27, 2025
|
% Change Since: -5.56%
|
Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Neutral
The earnings call for P3 Health Partners highlighted significant membership and revenue growth, strategic initiatives for future profitability, and leadership enhancements. However, the call also acknowledged challenges with decreased medical margins and elevated expenses, resulting in an adjusted EBITDA loss. Despite these challenges, the company's reaffirmed guidance and strategic initiatives suggest optimism for future performance.
Company Guidance
During the P3 Health Partners' Fourth Quarter 2024 Earnings Conference Call, guidance for 2025 was reaffirmed with projected revenues ranging from $1.35 billion to $1.5 billion and adjusted EBITDA between negative $35 million and $5 million positive. The company anticipates a growth in membership, increasing their total expectation to 109,000 to 119,000 due to ACO membership expansion. The revenue guidance reflects a 3.1% increase in MA funding, while medical margin is expected to be between $174 million to $210 million, translating to a per member per month (PMPM) range of $133 to $147. These figures are supported by operational efficiencies, including a $20 million reduction in operating expenses, and strategic contract renegotiations yielding $35 million in EBITDA improvements. Additionally, P3 Health Partners aims for a significant EBITDA improvement opportunity of over $130 million. Medical expenses are expected to normalize as benefit plan designs rationalize, contributing an estimated $30 to $35 PMPM in medical margin benefits. The company has also reduced its Part D exposure by 50% and plans further reductions. With an end-of-year cash balance of $38.8 million, excluding an additional $15 million received in early January 2025, P3 continues to assess its liquidity needs while focusing on profitability and sustainable growth.
Significant Membership and Revenue Growth
P3 Health Partners reported a 13% increase in membership from Q4 2023 to Q4 2024 and a 7% revenue growth to $371 million for the quarter. On an annual basis, 2024 revenues reached $1.5 billion, marking an 18% growth year over year.
Positive Guidance and Strategic Initiatives
The company reaffirmed its 2025 guidance for revenues between $1.35 billion and $1.5 billion and adjusted EBITDA from negative $35 million to positive $5 million. The company also highlighted a $130 million adjusted EBITDA improvement opportunity and success in operational efficiencies.
Leadership and Operational Enhancements
P3 Health Partners enhanced its senior leadership team with key hires, including a new Chief Legal and Compliance Officer. The company also introduced innovative programs like P3 Restore to reduce physician burnout.
Improved Medical Expense Management
The company reported decreased medical expenses, especially Part D expenses, and a significant reduction in Part D risk membership by 50%.
---

P3 Health Partners (PIII) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

PIII Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 07, 20252025 (Q1)
-0.16 / -
-0.16
Mar 27, 20252024 (Q4)
-0.08 / -0.36
-0.22-63.64% (-0.14)
Nov 12, 20242024 (Q3)
-0.04 / -0.31
-0.12-158.33% (-0.19)
Aug 07, 20242024 (Q2)
-0.04 / -0.15
-0.09-66.67% (-0.06)
May 08, 20242024 (Q1)
-0.13 / -0.16
-0.2227.27% (+0.06)
Mar 28, 20242023 (Q4)
-0.11 / -0.22
-2.2690.27% (+2.04)
Nov 08, 20232023 (Q3)
-0.18 / -0.12
-0.2755.56% (+0.15)
Aug 07, 20232023 (Q2)
-0.13 / -0.09
-3.7397.59% (+3.64)
May 10, 20232023 (Q1)
- / -
-0.254
Mar 31, 20232022 (Q4)
-0.47 / -0.22
-0.25413.39% (+0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

PIII Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Mar 27, 2025$0.18$0.17-5.56%
Nov 12, 2024$0.39$0.25-35.90%
Aug 07, 2024$0.62$0.59-4.84%
May 08, 2024$0.75$0.73-2.67%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does P3 Health Partners (PIII) report earnings?
P3 Health Partners (PIII) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
    What is P3 Health Partners (PIII) earnings time?
    P3 Health Partners (PIII) earnings time is at May 07, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is PIII EPS forecast?
          PIII EPS forecast for the fiscal quarter 2025 (Q1) is -0.16.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis